| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Fu Xi-Yong | Chief Executive Officer and Director Exhibit List: Ex. 24.1 - Power of Attorney, Director | C/O NOVABRIDGE BIOSCIENCES,, 2440 RESEARCH BOULEVARD, SUITE 400, ROCKVILLE | /s/ Xi-Yong (Sean) Fu | 18 Mar 2026 | 0002088625 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | NBP | Ordinary Shares | 59,823 | 18 Mar 2026 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | NBP | 2025 Employee Share Option (right to buy) | 18 Mar 2026 | Ordinary Shares | 1,245,000 | $1.07 | Direct | F1, F3, F4 | ||||||
| holding | NBP | Restricted Share Units | 18 Mar 2026 | Ordinary Shares | 1,245,000 | Direct | F1, F3, F5 |
| Id | Content |
|---|---|
| F1 | The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. |
| F2 | Reported securities are represented by 26,010 ADSs. |
| F3 | Number of underlying securities and exercise price expressed in terms of ADSs. |
| F4 | The option was granted on November 1, 2024. The option vests and becomes exercisable in four equal annual installments beginning on the first anniversary of the grant date. |
| F5 | Each restricted share unit ("RSU") represents a contingent right to receive one ADS. The RSUs vest, if at all, in four separate installments upon the Issuer's ADS's achieving certain specified prices per share. The RSUs have no expiration date. |
Chief Executive Officer and Director Exhibit List: Ex. 24.1 - Power of Attorney